Shotgun Sequencing in Diagnosing Febrile Neutropenia in Patients With Acute Myeloid Leukemia
NCT02856204 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 56
Last updated 2019-05-16
Summary
This research trial studies the shotgun sequencing of blood samples in diagnosing febrile neutropenia in patients with acute myeloid leukemia. Studying samples of blood from patients with acute myeloid leukemia in the laboratory may help identify pathogens and accurately diagnose infections such as febrile neutropenia.
Conditions
Interventions
- OTHER
-
Cytology Specimen Collection Procedure
Undergo collection of blood
- OTHER
-
Laboratory Biomarker Analysis
Correlative studies
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Stanley Deresinski · Stanford University
-
Steven Coutre · Stanford University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-08-31
- Primary Completion
- 2017-12-31
- Completion
- 2019-04-30
Countries
- United States
Study Locations
More Related Trials
-
PEG-rhG-CSF in Patients With Breast Cancer Receiving Chemotherapy to Prevent Neutropenia
NCT02805205 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Empirical Anti-Infective Therapy in Neutropenic Febrile Patients.
NCT07204522 ·Status: RECRUITING
-
The Oral Cavity as a Source of Febrile Neutropenia
NCT02702583 ·Status: COMPLETED
-
The Efficacy and Safety of PEG-rhG-CSF in Neutropenia After Chemotherapy
NCT02905916 ·Status: UNKNOWN ·Phase: PHASE4
-
An Analysis to Estimate Febrile Neutropenia (FN) in Patients Receiving Udenyca
NCT04662892 ·Status: UNKNOWN
-
Study of Recombinant Human Serum Albumin/Granulocyte Colony-Stimulating Factor Fusion Protein
NCT02465801 ·Status: COMPLETED ·Phase: PHASE2
-
Injection Regimen Trial of PEG-rhG-CSF During Breast Cancer Chemotherapy
NCT04477616 ·Status: COMPLETED ·Phase: PHASE2
-
Short-term Antibiotic Treatment for Unexplained Fever in Solid Cancer Patients With Febrile Neutropenia
NCT01450241 ·Status: WITHDRAWN ·Phase: NA
-
Fatigue and Symptom Burden in Low-Risk Cancer Patients Undergoing Treatment for Febrile Neutropenia
NCT00503854 ·Status: COMPLETED
-
Fusion Protein rHSA/GCSFclinical Study on Breast Cancer Patients
NCT03246009 ·Status: COMPLETED ·Phase: PHASE1
-
Real World Study of PEG-rhG-CSF in Prevention of Chemotherapy-induced Neutropenia
NCT03846414 ·Status: UNKNOWN
-
Recombinant Human Serum Albumin/Granulocyte Colony Stimulating Factor Fusion Protein for Breast Cancer Patients
NCT03251768 ·Status: COMPLETED ·Phase: PHASE2
-
Plasma Host-Microbe Proteomics to Predict Complications in High-risk Febrile Neutropenia
NCT07277387 ·Status: NOT_YET_RECRUITING
-
Telpegfilgrastim Injection to Reduce the Risk of Neutropenia in Patients With Solid Tumor
NCT07096479 ·Status: RECRUITING
-
Profiling Neutrophil Counts in Patients on Chemotherapy
NCT02806557 ·Status: UNKNOWN
-
Efficacy of Antibiotic Short Course for Bloodstream Infections in Acute Myeloid Leukemia Patients With Febrile Neutropenia
NCT04910698 ·Status: COMPLETED
-
Aranesp and Neulasta in Patients With Sarcoma Receiving Adriamycin and Ifosfamide
NCT00283621 ·Status: COMPLETED ·Phase: NA
-
Antimicrobial Revision in Persistent Febrile Neutropenia
NCT05784844 ·Status: WITHDRAWN ·Phase: PHASE4
-
The Efficacy and Safety of PEG-rhG-CSF in Preventing Chemotherapy-induced Neutropenia
NCT02761460 ·Status: UNKNOWN ·Phase: PHASE3
-
Probability of Optimal Target Attainment of Amikacin in Patients With Febrile Neutropenia During Treatment for a Hematological Disorder
NCT05689450 ·Status: COMPLETED
-
Risk Factors & Outcomes for Clinically Documented Infections in Pediatric Cancer Patients With Fever & Neutropenia
NCT02536599 ·Status: UNKNOWN
-
Prophylactic Use of PEG-rhG-CSF in Medium-high Risk of FN in Chemotherapy of Breast Cancer
NCT03618810 ·Status: UNKNOWN
-
Registry of Febrile Neutropenia and Invasive Fungal Infections
NCT01684189 ·Status: UNKNOWN
-
Safety and Efficacy Studies of rHSA/GCSF Fusion Protein For Injection to Treat Neutropenia
NCT01919710 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of AMG 114 Administered by Subcutaneous Injection for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies Receiving Multicycle Chemotherapy
NCT00119600 ·Status: TERMINATED ·Phase: PHASE1/PHASE2